Almotriptan for acute treatment of migraine: a randomized, double-blind, placebo-controlled study in Korea

被引：0
|
作者：
Chung, C. S.
Park, K. Y.
Moon, H. S.
Joo, S. A.
Song, K. S.
Kim, J. A.
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Yuhan Corp, Seoul, South Korea
来源：
CEPHALALGIA | 2006年 / 26卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1392 / 1392
页数：1
相关论文
共 50 条
  • [21] FLUNARIZINE IV IN THE ACUTE TREATMENT OF THE MIGRAINE ATTACK - A DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    SOYKA, D
    TANERI, Z
    OESTREICH, W
    SCHMIDT, R
    CEPHALALGIA, 1988, 8 : 35 - 40
  • [22] Almotriptan is an effective and well-tolerated treatment for migraine pain:: results of a randomized, double-blind, placebo-controlled clinical trial
    Dowson, AJ
    Massiou, H
    Laínez, JM
    Cabarrocas, X
    CEPHALALGIA, 2002, 22 (06) : 453 - 461
  • [23] Almotriptan is an effective and well-tolerated treatment for migraine pain:: results of a randomized, double-blind, placebo-controlled clinical trial
    Dowson, AJ
    Massiou, H
    Laínez, JM
    Cabarrocas, X
    CEPHALALGIA, 2003, 23 (02) : 453 - 461
  • [24] Intravenous lysine clonixinate for the acute treatment of severe migraine attacks: A double-blind, randomized, placebo-controlled study
    Krymchantowski, AV
    Silva, MMT
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2003, 64 (08): : 505 - 513
  • [25] Double-blind, randomized, placebo-controlled study to evaluate the efficacy and tolerability of rizatriptan with acetaminophen for the acute treatment of migraine
    Freitag, F. G.
    Diamond, M. L.
    Skobieranda, F.
    Diamond, S.
    HEADACHE, 2007, 47 (05): : 749 - 749
  • [26] Vaporized cannabis versus placebo for the acute treatment of migraine: a randomized, double-blind, placebo-controlled, crossover trial
    Schuster, Nathaniel
    Wallace, Mark
    Buse, Dawn
    Lee, Euyhyun
    Liu, Lin
    Marcotte, Thomas
    Sexton, Michelle
    CEPHALALGIA, 2023, 43 (1supp) : 23 - 24
  • [27] Treatment of Comorbid Migraine and Temporomandibular Disorders: A Factorial, Double-Blind, Randomized, Placebo-Controlled Study
    Goncalves, Daniela A. G.
    Camparis, Cinara M.
    Speciali, Jose G.
    Castanharo, Sabrina M.
    Ujikawa, Liliana T.
    Lipton, Richard B.
    Bigal, Marcelo E.
    JOURNAL OF OROFACIAL PAIN, 2013, 27 (04): : 325 - 335
  • [28] Memantine for Prophylactic Treatment of Migraine Without Aura: A Randomized Double-Blind Placebo-Controlled Study
    Noruzzadeh, Rezvan
    Modabbernia, Amirhossein
    Aghamollaii, Vajiheh
    Ghaffarpour, Majid
    Harirchian, Mohammad Hossein
    Salahi, Sarvenaz
    Nikbakht, Nikta
    Noruzi, Nahid
    Tafakhori, Abbas
    HEADACHE, 2016, 56 (01): : 95 - 103
  • [29] Galcanezumab in chronic migraine The randomized, double-blind, placebo-controlled REGAIN study
    Detke, Holland C.
    Goadsby, Peter J.
    Wang, Shufang
    Friedman, Deborah I.
    Selzler, Katherine J.
    Aurora, Sheena K.
    NEUROLOGY, 2018, 91 (24) : E2211 - E2221
  • [30] Randomized, double-blind, placebo-controlled comparison of oral naratriptan and oral sumatriptan in the acute treatment of migraine
    Dahlof, C
    Winter, P
    Whitehouse, H
    Hassani, H
    NEUROLOGY, 1997, 48 (03) : 8003 - 8003
12345